CLINICAL SUPPLY REGULATORY ARTICLES
What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release
Batch release delays rarely start in QA. Learn how CQV, digital integrity, risk-based validation, and global compliance keep clinical supplies moving.
CLINICAL SUPPLY REGULATORY VIDEOS
See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.
Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.
CLINICAL SUPPLY REGULATORY RESOURCES
-
![GettyImages-1163506017 labeling]( "IQVIA Labeling Compliance Solutions")
Learn how by having a strategy for “core-to-carton” compliance, drug developers can avoid risks for patients and their company.
-
![iStock-1219082584-delivery-direct-logistics]( "How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution")
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Comparator Sourcing: How And Why To Choose A Provider")
The right comparator sourcing strategy is critical. Review what sponsors need to consider when selecting the right provider in order to source the needed commercial products.
-
![GettyImages-1163506017 labeling]( "IMP Labeling: EU CTR Transition Considerations")
Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
![iStock-1209968955]( "Decentralized Clinical Trials: A Win For Patients, Sponsors, & Investigators")
Learn how the integral role of Direct-to-Patient Services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.
-
![Marken-CEO Headshot C]( "Clinical Trial Logistics Provider Of The Year")
How can you utilize state-of-the-art GMP-compliant depot networks and logistics hubs to maintain product quality and safety standards for complex therapies?
-
![GettyImages-1474595785 AI]( "Artificial Intelligence Regulation")
To make the best use of artificial intelligence (AI), drug sponsors need to understand where health authorities are drawing the lines.
